Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Olaiya T"'
Autor:
Clements DE; U.S. Medical and Clinical Affairs, Vaccines, GSK, Philadelphia, PA, USA., Olaiya T; U.S. Medical and Clinical Affairs, Vaccines, GSK, Philadelphia, PA, USA., Burman C; U.S. Medical and Clinical Affairs, Vaccines, GSK, Philadelphia, PA, USA., Herrera-Restrepo O; U.S. Medical and Clinical Affairs, Vaccines, GSK, Philadelphia, PA, USA., Sohn WY; Global Medical Affairs, GSK, Rockville, MD, USA., Folaranmi T; U.S. Medical and Clinical Affairs, Vaccines, GSK, Philadelphia, PA, USA., Abbing-Karahagopian V; Epidemiology, Value Evidence and Outcomes, GSK, Amsterdam, Netherlands., Marshall GS; Department of Pediatrics, Division of Pediatric Infectious Diseases, Norton Children's and the University of Louisville School of Medicine, Louisville, KY, USA., Conway JH; Department of Pediatrics, The University of Wisconsin-Madison School of Medicine & Public Health, Madison, WI, USA.
Publikováno v:
Expert review of vaccines [Expert Rev Vaccines] 2024 Jan-Dec; Vol. 23 (1), pp. 845-861. Date of Electronic Publication: 2024 Sep 11.